Biopharmaceutical classification of desloratadine – not all drugs are classified the easy way
The biopharmaceutical classification of drugs was designed as a basis for bio-waivers – a mechanism with the double ethical benefit of delivering new drug formulations to the market with less human testing and lower cost. However, many drugs defy simple classification because in vitro permeability a...
Saved in:
Main Authors: | Berginc Katja, Sibinovska Nadica, Žakelj Simon, Trontelj Jurij, Legen Igor |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2020-06-01
|
Series: | Acta Pharmaceutica |
Subjects: | |
Online Access: | https://doi.org/10.2478/acph-2020-0006 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Formulation and Evaluation of Ketoconazole Nano-suspension
by: Eriska Agustin, et al.
Published: (2023-12-01) -
Ownership Concentration and other Determinants of Covenants in Debt Contracts of Brazilian Publicly Listed Firms
by: Tatiana Albanez, et al.
Published: (2022-01-01) -
Biopharmaceutical characterisation of ciprofloxacin-metallic ion interactions: Comparative study into the effect of aluminium, calcium, zinc and iron on drug solubility and dissolution
by: Stojković Aleksandra, et al.
Published: (2014-03-01) -
Ashwagandha: Optimizing the Extraction and Electrospun Nanofiber Production
by: Maciej Jaskólski, et al.
Published: (2025-01-01) -
Observed Sprite Streamer Growth Rates
by: H. C. Stenbaek‐Nielsen, et al.
Published: (2025-01-01)